Compare LMAT & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMAT | PSNY |
|---|---|---|
| Founded | 1983 | 2017 |
| Country | United States | Sweden |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2006 | N/A |
| Metric | LMAT | PSNY |
|---|---|---|
| Price | $83.45 | $12.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $101.83 | N/A |
| AVG Volume (30 Days) | 188.5K | ★ 356.7K |
| Earning Date | 11-06-2025 | 09-03-2025 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | ★ 27.40 | N/A |
| EPS | ★ 2.32 | N/A |
| Revenue | $240,866,000.00 | ★ $2,547,619,000.00 |
| Revenue This Year | $15.17 | $49.69 |
| Revenue Next Year | $9.07 | $44.50 |
| P/E Ratio | $36.21 | ★ N/A |
| Revenue Growth | 13.07 | ★ 24.82 |
| 52 Week Low | $71.42 | $11.75 |
| 52 Week High | $105.55 | $42.60 |
| Indicator | LMAT | PSNY |
|---|---|---|
| Relative Strength Index (RSI) | 43.71 | 69.56 |
| Support Level | $82.52 | $11.75 |
| Resistance Level | $85.21 | $14.87 |
| Average True Range (ATR) | 2.32 | 1.11 |
| MACD | 0.03 | 1.30 |
| Stochastic Oscillator | 33.21 | 67.13 |
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.